These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2268501)

  • 21. Interleukin-6: a comprehensive review.
    Lotz M
    Cancer Treat Res; 1995; 80():209-33. PubMed ID: 8821579
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.
    Schirmacher P; Peters M; Ciliberto G; Blessing M; Lotz J; Meyer zum Büschenfelde KH; Rose-John S
    Am J Pathol; 1998 Aug; 153(2):639-48. PubMed ID: 9708822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-cytokine therapy for intractable hematologic diseases using monoclonal antibodies].
    Nishimoto N
    Nihon Naika Gakkai Zasshi; 2004 Feb; 93(2):390-6. PubMed ID: 15007951
    [No Abstract]   [Full Text] [Related]  

  • 24. [Human interleukin-6 receptors].
    Cai YP; Zhu LP
    Sheng Li Ke Xue Jin Zhan; 1992 Oct; 23(4):357-60. PubMed ID: 1302369
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone.
    Ohsaki Y; Takahashi S; Scarcez T; Demulder A; Nishihara T; Williams R; Roodman GD
    Endocrinology; 1992 Nov; 131(5):2229-34. PubMed ID: 1425421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interleukin 6 (IL-6)].
    Dohi K; Iwano M; Horii Y
    Nihon Rinsho; 1992 Dec; 50(12):2916-20. PubMed ID: 1491446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6 receptor and signals.
    Taga T; Hibi M; Murakami M; Saito M; Yawata H; Narazaki M; Hirata Y; Sugita T; Yasukawa K; Hirano T
    Chem Immunol; 1992; 51():181-204. PubMed ID: 1533128
    [No Abstract]   [Full Text] [Related]  

  • 28. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism.
    Takizawa H; Ohtoshi T; Ohta K; Yamashita N; Hirohata S; Hirai K; Hiramatsu K; Ito K
    Cancer Res; 1993 Sep; 53(18):4175-81. PubMed ID: 8364912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenously produced interleukin 6 is an accessory cytokine for dendritic cell hematopoiesis.
    Santiago-Schwarz F; Tucci J; Carsons SE
    Stem Cells; 1996 Mar; 14(2):225-31. PubMed ID: 8991542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
    Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
    Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A monoclonal antibody specific for the murine IL-6-receptor inhibits the growth of a mouse plasmacytoma in vivo.
    Coulie PG; Vink A; Van Snick J
    Curr Top Microbiol Immunol; 1990; 166():43-6. PubMed ID: 2073815
    [No Abstract]   [Full Text] [Related]  

  • 32. Interleukin-6 in biology and medicine.
    Akira S; Taga T; Kishimoto T
    Adv Immunol; 1993; 54():1-78. PubMed ID: 8379461
    [No Abstract]   [Full Text] [Related]  

  • 33. Interleukin-6 autoantibodies: possible biological and clinical significance.
    Hansen MB; Svenson M; Diamant M; Abell K; Bendtzen K
    Leukemia; 1995 Jul; 9(7):1113-5. PubMed ID: 7630180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is IL-6 both a cytokine and a neurotrophic factor?
    Wagner JA
    J Exp Med; 1996 Jun; 183(6):2417-9. PubMed ID: 8676061
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury.
    Yan HQ; Banos MA; Herregodts P; Hooghe R; Hooghe-Peters EL
    Eur J Immunol; 1992 Nov; 22(11):2963-71. PubMed ID: 1425920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [IL-6 receptor and signal transduction pathway].
    Nakajima K; Hirano T
    Tanpakushitsu Kakusan Koso; 1991 Mar; 36(4):687-95. PubMed ID: 2063018
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyper-IL-6 and liver diseases].
    Qie CH; Qin B
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):238-40. PubMed ID: 16556432
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo.
    Suzuki H; Yasukawa K; Saito T; Goitsuka R; Hasegawa A; Ohsugi Y; Taga T; Kishimoto T
    Eur J Immunol; 1992 Aug; 22(8):1989-93. PubMed ID: 1639101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The soluble interleukin-2 receptor in haematological disorders.
    Pizzolo G; Chilosi M; Semenzato G
    Br J Haematol; 1987 Dec; 67(4):377-80. PubMed ID: 3122815
    [No Abstract]   [Full Text] [Related]  

  • 40. Hematopathology of interleukin 6-type cytokines.
    Hawley RG
    Stem Cells; 1994; 12 Suppl 1():155-71. PubMed ID: 7696960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.